Myocardial Reperfusion Injury D015428

Related MeSH Hierarchy (5)

Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Cardiomyopathies » Myocardial Reperfusion Injury

Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Myocardial Ischemia » Myocardial Reperfusion Injury

Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Myocardial Ischemia » Myocardial Reperfusion Injury

Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Reperfusion Injury » Myocardial Reperfusion Injury

Description

Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm.   MeSH

Hierarchy View


Phase 3 Indicated Drugs (2)

Phase 2 Indicated Drugs (3)


Organization Involved with Other Experimental Indications (3)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.